TYRA compared with JANX: revenue, margins and what each company keeps, and the suppliers and customers both name

TYRATyra Biosciences, Inc.

Mkt capRevenueRevenue

JANXJanux Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

TYRATyra Biosciences, Inc.

JANXJanux Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TYRA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±26.7%▼−20.97%×0.79

May 13 '26±12.3%▲+3.79%×0.31

Q1 FY26±18.0%▲+1.51%×0.08

Nov 6 '25±25.6%▼−3.64%×0.14

JANX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.7%▼−1.55%×0.15

May 8 '26±9.4%▼−2.51%×0.27

= impliedTYRA realized, solidJANX realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.2%

▼−1.38%

×0.11

Q3 FY25±21.6%▼−7.61%×0.35

TYRATyra Biosciences, Inc.

21.08▼−1.86%· post 21.08

Mkt cap$1.3BRevenue—

JANXJanux Therapeutics, Inc.

17.48▼−1.96%· post 17.23

ClosedOct 30 '26

Mkt cap$1.1BRevenue$10MQ2 FY26

Compare

ClosedOct 30 '26

TYRATyra Biosciences, Inc.

JANXJanux Therapeutics, Inc.

21.08▼−1.86%post 21.08

Price

17.48▼−1.96%post 17.23

$1.3B

Mkt cap

$1.1B

—

Revenue

$10MQ2 FY26

TYRA21.08▼−1.86%vsJANX17.48▼−1.96%ClosedOct 30 '26